iBio Inc (AMEX:IBIO) traded at $2.11 at close of the session on Friday, April 05, made a downward move of -15.26% on its previous day’s price.
Looking at the stock we see that its previous close was $2.49 and the beta (5Y monthly) reads -3.80 . In terms of its 52-week price range, IBIO has a high of $29.57 and a low of $1.02. The company’s stock has gained about 75.83% over that past 30 days.
iBio Inc has a market cap of $17.98 million and is expected to release its quarterly earnings report on May 13, 2024 – May 17, 2024.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the IBIO stock, short term indicators assign the stock an average of Hold, while medium term indicators assign it an average of 50% Sell. Long term indicators on average place the stock in the category of 50% Sell.
Looking further, we note the current price level is 21.60% off its SMA20 and 50.46% from its 50-day simple moving average. The RSI (14) is pointing at 53.19 while the volatility over the past week is 20.45% and jumps to 13.02% over the past one month. The beta value is -3.41, while the average true range (ATR) is currently pointing at 0.42.
Coming back to iBio Inc (AMEX:IBIO), we note that the average 3-month trading volume was 3.82 million, while that of the preceding 10-day period stands at 23.27 million. Current shares outstanding are 8.52 million.
The insiders hold 0.39% of the company’s shares while institutions hold 10.00%. The data shows that short shares as of Mar 15, 2024, stood at 59320.0 at a short ratio of 0.43. This represents a 1.70% short interest in shares outstanding on Mar 15, 2024. Shares short rose in March from the previous month at 13990.0. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 54.01% up in year-to-date price movement.
